Biomarker Can Help Predict Preeclampsia Risk in Women with Sickle Cell Disease
American Society of Hematology
Findings pave way for more effective pregnancy management in higher risk patient population
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers